Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
A new electroporation-based CRISPR-Cas9 method could improve gene editing for CAR-T and other cell therapies.
Modifying tumor cells instead of immune cells from patients is showing promising results in animal models of breast and brain cancer.
AMPLEXOR Life Sciences: Helping Life Sciences Firms Optimize Routine Document Production
MIT researchers have developed nanoparticles with drug payloads that enhance T cells' tumor-killing power.
Researchers at Mount Sinai say they’ve identified two biomarkers that may improve the treatment of an aggressive subtype of bladder cancer.
The increasing demand for innovation in research and the related pressures to deliver on the most promising findings from discovery are also driving the need…
Scientists are adding antigenic epitopes to an old class of antibiotic to trigger an immune response against Gram-negative bacteria.
An amino acid switch controls protein expression in cultured cells and mouse embryos and could be used to control gene therapies.
Biotech news over the last week included insight into a protein that powers the flu and an immune-boosting treatment for prostate cancer.
Scientists have amassed evidence that the metformin's ability to target cell metabolism could help repair the lung.
A mouse study shed light on the mechanism that causes an inherited form of deafness, as well as a potential treatment.
A protein called called TWIK2 could pave the way for the development of drugs that tamp down massive inflammatory responses.